Casdin Capital, LLC Q2 2020 Filing
Filed August 14, 2020
Portfolio Value
$1.7T
Holdings
42
Report Date
Q2 2020
Filing Type
13F-HR
All Holdings (42 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | NVTA1EURINVITAE CORP | 9,033,943 | $273.6B | 16.19% | |
| 2 | 2L9BLUEPRINT MEDICINES CORP | 1,550,000 | $120.9B | 7.15% | |
| 3 | FATEFATE THERAPEUTICS INC | 3,050,000 | $104.6B | 6.19% | |
| 4 | SRPTSAREPTA THERAPEUTICS INC | 530,000 | $85.0B | 5.03% | |
| 5 | —MYOKARDIA INC | 870,000 | $84.1B | 4.97% | |
| 6 | ALNYALNYLAM PHARMACEUTICALS INC | 550,000 | $81.5B | 4.82% | |
| 7 | BLFSBIOLIFE SOLUTIONS INC | 4,849,524 | $79.3B | 4.69% | |
| 8 | —BLUEBIRD BIO INC | 1,105,000 | $67.4B | 3.99% | |
| 9 | AGIOAGIOS PHARMACEUTICALS INC | 1,070,000 | $57.2B | 3.39% | |
| 10 | CDXSCODEXIS INC | 4,692,732 | $53.5B | 3.17% | |
| 11 | BNRBURNING ROCK BIOTECH LTD | 1,730,786 | $46.7B | 2.77% | |
| 12 | TWSTTWIST BIOSCIENCE CORP | 1,000,000 | $45.3B | 2.68% | |
| 13 | CDNACAREDX INC | 1,193,335 | $42.3B | 2.50% | |
| 14 | RVMDREVOLUTION MEDICINES INC | 1,334,536 | $42.1B | 2.49% | |
| 15 | ADVMCHFADVERUM BIOTECHNOLOGIES INC | 1,865,000 | $38.9B | 2.30% | |
| 16 | ADPTADAPTIVE BIOTECHNOLOGIES COR | 713,125 | $34.5B | 2.04% | |
| 17 | GBIOGBXGENERATION BIO CO | 1,611,214 | $33.8B | 2.00% | |
| 18 | DNLIDENALI THERAPEUTICS INC | 1,310,000 | $31.7B | 1.87% | |
| 19 | —CONSTELLATION PHARMCETICLS I | 980,000 | $29.4B | 1.74% | |
| 20 | ONCBEIGENE LTD | 150,000 | $28.3B | 1.67% | |
| 21 | ALLOALLOGENE THERAPEUTICS INC | 625,000 | $26.8B | 1.58% | |
| 22 | FULCFULCRUM THERAPEUTICS INC | 1,441,176 | $26.4B | 1.56% | |
| 23 | ALECALECTOR INC | 1,076,039 | $26.3B | 1.56% | |
| 24 | —MAGENTA THERAPEUTICS INC | 3,346,034 | $25.1B | 1.49% | |
| 25 | AMRSEURAMYRIS INC | 5,349,376 | $22.8B | 1.35% | |
| 26 | CRSPCRISPR THERAPEUTICS AG | 266,430 | $19.6B | 1.16% | |
| 27 | GBTUSDGLOBAL BLOOD THERAPEUTICS IN | 300,000 | $18.9B | 1.12% | |
| 28 | DMTKQDERMTECH INC | 1,428,572 | $18.9B | 1.12% | |
| 29 | ZLABZAI LAB LTD | 190,000 | $15.6B | 0.92% | |
| 30 | GBYSANGAMO THERAPEUTICS INC | 1,455,000 | $13.0B | 0.77% | |
| 31 | 2JQGRITSTONE ONCOLOGY INC | 1,850,373 | $12.3B | 0.73% | |
| 32 | BDTXBLACK DIAMOND THERAPEUTICS I | 289,395 | $12.2B | 0.72% | |
| 33 | ILMNILLUMINA INC | 30,000 | $11.1B | 0.66% | |
| 34 | BMY-RBRISTOL-MYERS SQUIBB CO | 2,950,000 | $10.6B | 0.63% | |
| 35 | ORTXUSDORCHARD THERAPEUTICS PLC | 1,650,000 | $9.9B | 0.59% | |
| 36 | VYGRVOYAGER THERAPEUTICS INC | 750,000 | $9.5B | 0.56% | |
| 37 | ORICORIC PHARMACEUTICALS INC | 251,515 | $8.5B | 0.50% | |
| 38 | LEGNLEGEND BIOTECH CORP | 135,000 | $5.7B | 0.34% | |
| 39 | —TURNING POINT THERAPEUTICS I | 75,000 | $4.8B | 0.29% | |
| 40 | —ZYMEWORKS INC | 130,000 | $4.7B | 0.28% | |
| 41 | DCPHEURDECIPHERA PHARMACEUTICALS IN | 65,000 | $3.9B | 0.23% | |
| 42 | STOKSTOKE THERAPEUTICS INC | 120,000 | $2.9B | 0.17% |